Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP431561.RAEoDxfulfM2v5I2QWgWVmCbn3R4k5PBoLEqP8QZO3QYQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP431561.RAEoDxfulfM2v5I2QWgWVmCbn3R4k5PBoLEqP8QZO3QYQ130_assertion type Assertion NP431561.RAEoDxfulfM2v5I2QWgWVmCbn3R4k5PBoLEqP8QZO3QYQ130_head.
- NP431561.RAEoDxfulfM2v5I2QWgWVmCbn3R4k5PBoLEqP8QZO3QYQ130_assertion description "[Anti-CD19-BB-zeta lymphocytes were remarkably effective in cocultures with bone marrow mesenchymal cells, and against leukemic cells from patients with drug-resistant ALL: as few as 1% anti-CD19-BB-zeta-transduced T cells eliminated most ALL cells within 5 days.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431561.RAEoDxfulfM2v5I2QWgWVmCbn3R4k5PBoLEqP8QZO3QYQ130_provenance.
- NP431561.RAEoDxfulfM2v5I2QWgWVmCbn3R4k5PBoLEqP8QZO3QYQ130_assertion evidence source_evidence_literature NP431561.RAEoDxfulfM2v5I2QWgWVmCbn3R4k5PBoLEqP8QZO3QYQ130_provenance.
- NP431561.RAEoDxfulfM2v5I2QWgWVmCbn3R4k5PBoLEqP8QZO3QYQ130_assertion SIO_000772 14961035 NP431561.RAEoDxfulfM2v5I2QWgWVmCbn3R4k5PBoLEqP8QZO3QYQ130_provenance.
- NP431561.RAEoDxfulfM2v5I2QWgWVmCbn3R4k5PBoLEqP8QZO3QYQ130_assertion wasDerivedFrom befree-2016 NP431561.RAEoDxfulfM2v5I2QWgWVmCbn3R4k5PBoLEqP8QZO3QYQ130_provenance.
- NP431561.RAEoDxfulfM2v5I2QWgWVmCbn3R4k5PBoLEqP8QZO3QYQ130_assertion wasGeneratedBy ECO_0000203 NP431561.RAEoDxfulfM2v5I2QWgWVmCbn3R4k5PBoLEqP8QZO3QYQ130_provenance.